110 related articles for article (PubMed ID: 9741956)
1. Differential in vitro hepatic and intestinal metabolism of ifosfamide in the rat.
Lu H; Chan KK
Xenobiotica; 1998 Aug; 28(8):779-84. PubMed ID: 9741956
[TBL] [Abstract][Full Text] [Related]
2. Stereoselectivity in metabolism of ifosfamide by CYP3A4 and CYP2B6.
Lu H; Wang JJ; Chan KK; Philip PA
Xenobiotica; 2006 May; 36(5):367-85. PubMed ID: 16854777
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective pharmacokinetics of ifosfamide in male and female rats.
Wang JJ; Lu H; Chan KK
AAPS PharmSci; 2000; 2(2):E17. PubMed ID: 11741233
[TBL] [Abstract][Full Text] [Related]
4. Renal clearance of ifosfamide.
Springate J; Zamlauski-Tucker MJ; Lu H; Chan KK
Drug Metab Dispos; 1997 Sep; 25(9):1081-2. PubMed ID: 9311624
[TBL] [Abstract][Full Text] [Related]
5. Gender difference in ifosfamide metabolism by human liver microsomes.
Schmidt R; Baumann F; Hanschmann H; Geissler F; Preiss R
Eur J Drug Metab Pharmacokinet; 2001; 26(3):193-200. PubMed ID: 11695720
[TBL] [Abstract][Full Text] [Related]
6. Analysis of ifosfamide, 4-hydroxyifosfamide, N2-dechloroethylifosfamide, N3-dechloroethylifosfamide and iphosphoramide mustard in plasma by gas chromatography-mass spectrometry.
Wang JJ; Chan KK
J Chromatogr B Biomed Appl; 1995 Dec; 674(2):205-17. PubMed ID: 8788150
[TBL] [Abstract][Full Text] [Related]
7. Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide.
Huang Z; Roy P; Waxman DJ
Biochem Pharmacol; 2000 Apr; 59(8):961-72. PubMed ID: 10692561
[TBL] [Abstract][Full Text] [Related]
8. Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes.
Granvil CP; Madan A; Sharkawi M; Parkinson A; Wainer IW
Drug Metab Dispos; 1999 Apr; 27(4):533-41. PubMed ID: 10101149
[TBL] [Abstract][Full Text] [Related]
9. Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms.
Calinski DM; Zhang H; Ludeman S; Dolan ME; Hollenberg PF
Drug Metab Dispos; 2015 Jul; 43(7):1084-90. PubMed ID: 25934575
[TBL] [Abstract][Full Text] [Related]
10. Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation.
McCune JS; Risler LJ; Phillips BR; Thummel KE; Blough D; Shen DD
Drug Metab Dispos; 2005 Jul; 33(7):1074-81. PubMed ID: 15821045
[TBL] [Abstract][Full Text] [Related]
11. Measurement of 4-hydroxylation of ifosfamide in human liver microsomes using the estimation of free and protein-bound acrolein and codetermination of keto- and carboxyifosfamide.
Preiss R; Schmidt R; Baumann F; Hanschmann H; Hauss J; Geissler F; Pahlig H; Ratzewiss B
J Cancer Res Clin Oncol; 2002 Jul; 128(7):385-92. PubMed ID: 12136253
[TBL] [Abstract][Full Text] [Related]
12. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
Yu L; Waxman DJ
Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
[TBL] [Abstract][Full Text] [Related]
13. Studies on the side-chain hydroxylation of ifosfamide and its bromo analogue.
Misiura K; Kinas RW; Kuśnierczyk H
Bioorg Med Chem Lett; 2002 Feb; 12(3):427-31. PubMed ID: 11814813
[TBL] [Abstract][Full Text] [Related]
14. Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide.
Walker D; Flinois JP; Monkman SC; Beloc C; Boddy AV; Cholerton S; Daly AK; Lind MJ; Pearson AD; Beaune PH
Biochem Pharmacol; 1994 Mar; 47(7):1157-63. PubMed ID: 8161344
[TBL] [Abstract][Full Text] [Related]
15. Activation of the anticancer drugs cyclophosphamide and ifosfamide by cytochrome P450 BM3 mutants.
Vredenburg G; den Braver-Sewradj S; van Vugt-Lussenburg BM; Vermeulen NP; Commandeur JN; Vos JC
Toxicol Lett; 2015 Jan; 232(1):182-92. PubMed ID: 25448283
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective metabolism of ifosfamide by the kidney.
Aleksa K; Ito S; Koren G
Chirality; 2006 Jun; 18(6):398-405. PubMed ID: 16575879
[TBL] [Abstract][Full Text] [Related]
17. Enantiomer-enantiomer interaction of ifosfamide in the rat.
Lu H; Wang JJ; Chan KK
Xenobiotica; 2006 Jun; 36(6):535-49. PubMed ID: 16865821
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective metabolism of ifosfamide by human P-450s 3A4 and 2B6. Favorable metabolic properties of R-enantiomer.
Roy P; Tretyakov O; Wright J; Waxman DJ
Drug Metab Dispos; 1999 Nov; 27(11):1309-18. PubMed ID: 10534317
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
[TBL] [Abstract][Full Text] [Related]
20. Effects of phenobarbital on stereoselective metabolism of ifosfamide in rats.
Lu H; Wang JJ; Chan KK; Young D
Drug Metab Dispos; 1998 May; 26(5):476-82. PubMed ID: 9571229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
